ATE251222T1 - Verfahren zur bestimung von ki-ras mutationen und dieses leistender testsatz - Google Patents

Verfahren zur bestimung von ki-ras mutationen und dieses leistender testsatz

Info

Publication number
ATE251222T1
ATE251222T1 AT96939373T AT96939373T ATE251222T1 AT E251222 T1 ATE251222 T1 AT E251222T1 AT 96939373 T AT96939373 T AT 96939373T AT 96939373 T AT96939373 T AT 96939373T AT E251222 T1 ATE251222 T1 AT E251222T1
Authority
AT
Austria
Prior art keywords
ras mutations
determining
test set
pcr
set performing
Prior art date
Application number
AT96939373T
Other languages
German (de)
English (en)
Inventor
Dagfinn Ogreid
Arve Ulvik
Jan Jacob Koornstra
Original Assignee
Nordiag As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nordiag As filed Critical Nordiag As
Application granted granted Critical
Publication of ATE251222T1 publication Critical patent/ATE251222T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Electrophonic Musical Instruments (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Control And Other Processes For Unpacking Of Materials (AREA)
  • Saccharide Compounds (AREA)
  • Holo Graphy (AREA)
  • Electrically Operated Instructional Devices (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
AT96939373T 1995-11-17 1996-11-15 Verfahren zur bestimung von ki-ras mutationen und dieses leistender testsatz ATE251222T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO954667A NO954667D0 (no) 1995-11-17 1995-11-17 Fremgangsmåte til deteksjon av Ki-ras mutasjoner
PCT/NO1996/000271 WO1997019191A1 (en) 1995-11-17 1996-11-15 Method for detection of ki-ras mutations and kit to perform it

Publications (1)

Publication Number Publication Date
ATE251222T1 true ATE251222T1 (de) 2003-10-15

Family

ID=19898772

Family Applications (2)

Application Number Title Priority Date Filing Date
AT96939373T ATE251222T1 (de) 1995-11-17 1996-11-15 Verfahren zur bestimung von ki-ras mutationen und dieses leistender testsatz
AT03020560T ATE318934T1 (de) 1995-11-17 1996-11-15 Verfahren zum nachweis von ki-ras mutationen

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT03020560T ATE318934T1 (de) 1995-11-17 1996-11-15 Verfahren zum nachweis von ki-ras mutationen

Country Status (12)

Country Link
US (1) US6440661B1 (OSRAM)
EP (2) EP1394272B1 (OSRAM)
JP (1) JP2000500346A (OSRAM)
AT (2) ATE251222T1 (OSRAM)
AU (1) AU723980C (OSRAM)
DE (2) DE69635848T2 (OSRAM)
DK (2) DK1394272T3 (OSRAM)
ES (2) ES2262930T3 (OSRAM)
NO (2) NO954667D0 (OSRAM)
NZ (1) NZ322619A (OSRAM)
PT (2) PT1394272E (OSRAM)
WO (1) WO1997019191A1 (OSRAM)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9715034D0 (en) * 1997-07-18 1997-09-24 Zeneca Ltd Assay
DE60029092T2 (de) * 1999-04-09 2007-02-01 Exact Sciences Corp., Marlborough Verfahren zur detektion von nukleinsäuren, welche auf krebs hinweisen
US6531302B1 (en) * 1999-04-12 2003-03-11 Nanogen/Becton Dickinson Partnership Anchored strand displacement amplification on an electronically addressable microchip
US6849403B1 (en) 1999-09-08 2005-02-01 Exact Sciences Corporation Apparatus and method for drug screening
US6586177B1 (en) 1999-09-08 2003-07-01 Exact Sciences Corporation Methods for disease detection
CA2394921A1 (en) 1999-12-07 2001-06-14 Anthony P. Shuber Supracolonic aerodigestive neoplasm detection
US7087414B2 (en) 2000-06-06 2006-08-08 Applera Corporation Methods and devices for multiplexing amplification reactions
EP2351853A1 (en) * 2000-06-06 2011-08-03 Life Technologies Corporation Method and devices for multiplexing amplification reactions
US6605451B1 (en) * 2000-06-06 2003-08-12 Xtrana, Inc. Methods and devices for multiplexing amplification reactions
US7482116B2 (en) 2002-06-07 2009-01-27 Dna Genotek Inc. Compositions and methods for obtaining nucleic acids from sputum
JP2006508662A (ja) 2002-12-04 2006-03-16 アプレラ コーポレイション ポリヌクレオチドの多重増幅
US20080124714A1 (en) * 2004-05-14 2008-05-29 Exact Sciences Corporation Method for Stabilizing Biological Samples for Nucleic Acid Analysis
US20070134709A1 (en) * 2005-12-14 2007-06-14 Xiping Xu Usages of MTHFR gene polymorphisms in predicting homocysteine level, disease risk, and treatment effects and related methods and kit
GB2435512A (en) 2006-02-23 2007-08-29 Mologic Ltd A binding assay and assay device
CN101449162B (zh) 2006-05-18 2013-07-31 分子压型学会股份有限公司 确定针对病状的个性化医疗介入的系统和方法
US8768629B2 (en) 2009-02-11 2014-07-01 Caris Mpi, Inc. Molecular profiling of tumors
EP2318552B1 (en) 2008-09-05 2016-11-23 TOMA Biosciences, Inc. Methods for stratifying and annotating cancer drug treatment options
EP2730662A1 (en) 2008-11-12 2014-05-14 Caris Life Sciences Luxembourg Holdings Methods and systems of using exosomes for determining phenotypes
WO2011082321A1 (en) * 2009-12-31 2011-07-07 Van Andel Research Institute Methods for diagnosing the malignant potential of pancreatic cystic lesions
US9128101B2 (en) 2010-03-01 2015-09-08 Caris Life Sciences Switzerland Holdings Gmbh Biomarkers for theranostics
BR112012025593A2 (pt) 2010-04-06 2019-06-25 Caris Life Sciences Luxembourg Holdings biomarcadores em circulação para doença
CA2810931C (en) 2010-09-24 2018-04-17 The Board Of Trustees Of The Leland Stanford Junior University Direct capture, amplification and sequencing of target dna using immobilized primers
GB201107466D0 (en) 2011-05-05 2011-06-15 Loktionov Alexandre Device and method for non-invasive collection of colorectal mucocellular layer and disease detection
CN102796811B (zh) * 2011-05-26 2013-12-18 上海赛安生物医药科技有限公司 检测kras突变的试剂及方法
EP2721140B1 (en) 2011-06-19 2016-11-23 Abogen, Inc. Devices, solutions and methods for sample collection
EP2780473B1 (en) * 2011-11-17 2017-07-19 The Johns Hopkins University Differential identification of pancreatic cysts
WO2014085826A2 (en) * 2012-11-30 2014-06-05 Applied Proteomics, Inc. Method for evaluation of presence of or risk of colon tumors
SG11201607364RA (en) 2014-03-07 2016-10-28 Dna Genotek Inc Composition and method for stabilizing nucleic acids in biological samples
JP2018517892A (ja) 2015-04-10 2018-07-05 アプライド プロテオミクス，インク． 結腸直腸癌と進行腺腫を検知するためのタンパク質バイオマーカーパネル
US10753936B2 (en) 2016-07-22 2020-08-25 Van Andel Research Institute Method of detecting the level of a glycan
TW202015719A (zh) 2018-06-19 2020-05-01 美商尼恩醫療公司 新抗原及其用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4871838A (en) * 1985-07-23 1989-10-03 The Board Of Rijks Universiteit Leiden Probes and methods for detecting activated ras oncogenes
US5137806A (en) * 1989-12-11 1992-08-11 Board Of Regents, The University Of Texas System Methods and compositions for the detection of sequences in selected DNA molecules
IL97222A (en) * 1990-02-16 1995-08-31 Orion Yhtymae Oy Method and reagent for determining specific nucleotide variations
ATE253645T1 (de) 1992-04-01 2003-11-15 Univ Johns Hopkins Med Verfahren zur bestimmung von säugetier nukleinsäuren aus stuhlproben und dafür benötigte reagenzien
JP2001507921A (ja) * 1992-04-27 2001-06-19 トラスティーズ オブ ダートマス カレッジ 生物学的液体中の遺伝子配列の検出
JPH06167492A (ja) * 1992-11-30 1994-06-14 Otsuka Pharmaceut Co Ltd 変異癌遺伝子の検出測定方法
DE19512369A1 (de) * 1995-04-01 1996-10-02 Boehringer Mannheim Gmbh Vorrichtung zur Isolierung von Nukleinsäuren

Also Published As

Publication number Publication date
JP2000500346A (ja) 2000-01-18
DE69635848T2 (de) 2006-11-30
AU723980C (en) 2002-10-24
EP1394272B1 (en) 2006-03-01
DK1394272T3 (da) 2006-07-03
DK0868529T3 (da) 2004-02-02
DE69630234D1 (de) 2003-11-06
ATE318934T1 (de) 2006-03-15
PT1394272E (pt) 2006-07-31
NO982246D0 (no) 1998-05-15
AU723980B2 (en) 2000-09-07
WO1997019191A1 (en) 1997-05-29
AU7656996A (en) 1997-06-11
ES2262930T3 (es) 2006-12-01
NO954667D0 (no) 1995-11-17
EP0868529A1 (en) 1998-10-07
EP0868529B1 (en) 2003-10-01
ES2208766T3 (es) 2004-06-16
DE69635848D1 (de) 2006-04-27
NZ322619A (en) 1999-04-29
PT868529E (pt) 2004-02-27
EP1394272A1 (en) 2004-03-03
DE69630234T2 (de) 2004-08-19
NO324963B1 (no) 2008-01-14
US6440661B1 (en) 2002-08-27
NO982246L (no) 1998-07-07

Similar Documents

Publication Publication Date Title
ATE251222T1 (de) Verfahren zur bestimung von ki-ras mutationen und dieses leistender testsatz
ATE90792T1 (de) Diagnostische verfahren zum nachweis von lymphomen bei menschen.
DE68928266D1 (de) Verfahren und vorrichtung zur amperometrischen diagnostischen analyse
DE69132098D1 (de) Verfahren zur amplifikation von nukleinsäuren
ATE219245T1 (de) Biosensor, iontophoretischen probenahmesystem, und verfahren zur seiner anwendung
DE60029369D1 (de) Verfahren und Sondenset zur Erkennung von Krebs
EP0131052A4 (en) DETECTION, IDENTIFICATION AND QUANTIFICATION OF ORGANISMS AND VIRUSES.
DE68924779D1 (de) Vorrichtung und verfahren zum nachweis von chemischen spezies.
EP0668777A4 (en) PROSTATE SPECIFIC MEMBRANE ANTIGEN.
ATE454468T1 (de) Nachweis der instabilität von mikrosatelliten und verwendung davon bei der tumordiagnose
ATE310819T1 (de) Säugetieren apoptosis inhibitorprotein genfamilie,primers, probes und verfahren zur nachweis
DE69230736D1 (de) Verfahren zur Charakterisierung genomischer DNA
DE69026449D1 (de) Verfahren zur Diagnose und zur Amplifikation, das das Problem einer Fehlpaarung zwischen Primer und Zielsequenz am 3'-Ende des Primers überwindet
ATE360092T1 (de) Nukleinsäureprimer und -sonden zur detektion onkogener humaner papillomaviren
DE69929882D1 (de) Verfahren und vorrichtung zur nukleinsäurereinigung
DE69833660D1 (de) Nukleinsäuresonden zur detektion von candida-spezies
DE60007352D1 (de) Genetischer test zur bestimmung der nicht-wirksamkeit einer behandlung mit statinmedikamenten
EP0128018A3 (en) Molecular genetic probe, and method of forming same, assay technique and kit using said molecular genetic probe
DE3765147D1 (de) Verfahren und reagenz zur bestimmung von gesamt-bilirubin.
DE60125171D1 (de) Verfahren zur detektion und quantifizierung von menschlichen p450-molekülen und sonde und kit für dieses verfahren
ATE133209T1 (de) Verfahren zur detektion und quantitativen bestimmung von nitrosomonas-stämmen in abwässern oder boden
DE69531505D1 (de) Verfahren zur zellerkennung
AU2283792A (en) Direct detection of hepatitis c virus rna
ATE64470T1 (de) Verfahren und zusammensetzungen zur bestimmung von heparin.
EP1241269A3 (en) Method for detecting REG-like protein and nucleic acids coding therefor

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0868529

Country of ref document: EP

REN Ceased due to non-payment of the annual fee